AstraZeneca (LON: AZN) Lifts Full-Year Outlook After Q3 Beat, Doubles Down on US Investments
Drugmaker AstraZeneca (LON: AZN) lifted its annual sales and profit forecast for the second time this year on Tuesday, helped […]
Healthcare
US Minority Veterans Face Unequal Access to Ozempic and Wegovy, Study Finds
U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk’s (NYSE: NVO) highly in-demand drugs for diabetes
US Minority Veterans Face Unequal Access to Ozempic and Wegovy, Study Finds Read More »
Healthcare
Evotec (NASDAQ: EVO) Stock Surges After Triton Acquires Nearly 10% Stake, Mulls Buyout Bid
Shares in Evotec (NASDAQ: EVO) soared 22% on Monday after private equity firm Triton confirmed a close to 10% stake
Grifols (NASDAQ: GRFS) Reaffirms 2024 Outlook as Core Earnings Rise 27% in Q3
MADRID – On Thursday, Grifols (NASDAQ: GRFS), the Spanish drugmaker, said it was on track to meet its targets for
Grifols (NASDAQ: GRFS) Reaffirms 2024 Outlook as Core Earnings Rise 27% in Q3 Read More »
Oaktree Capital Urges Indivior to Refresh Board
Oaktree Capital Management, the investment fund, has urged British drugmaker Indivior (NASDAQ: INDV) to cooperate with the fund in refreshing
Healthcare
Qiagen (NYSE: QGEN) Reports Q3 Revenue Growth
On Wednesday, Qiagen (NYSE: QGEN) reported a rise in third-quarter revenue, owing to strong sales of its diagnostic devices. The
Gilead Sciences (NASDAQ: GILD) Stock Jumps on Upbeat Q3 Results, Full-Year Outlook
Gilead Sciences (NASDAQ: GILD) reported third-quarter financial results that handily beat Wall Street expectations on Wednesday as sales climbed 7%,
Gilead Sciences (NASDAQ: GILD) Stock Jumps on Upbeat Q3 Results, Full-Year Outlook Read More »
Novo Nordisk CFO Forecasts High-Teens Sales Growth for 2025
LONDON – Novo Nordisk’s (NYSE: NVO) sales growth next year could be in the high teens in percentage terms, Chief
Novo Nordisk CFO Forecasts High-Teens Sales Growth for 2025 Read More »
Teva Pharm CEO Says Will Work Productively with Trump Administration
JERUSALEM – Teva Pharmaceutical Industries (NYSE: TEVA) expects to work productively with the incoming Trump administration in the United States,
Teva Pharm CEO Says Will Work Productively with Trump Administration Read More »
AstraZeneca’s China Chief in Custody, Believes Arrest Unrelated to Insurance Probe
LONDON – On Wednesday, AstraZeneca (NASDAQ: AZN) said its China president Leon Wang had been detained by Chinese authorities and,
AstraZeneca’s China Chief in Custody, Believes Arrest Unrelated to Insurance Probe Read More »
Novo Nordisk Lifts Curbs on Wegovy Prescriptions in the US, CEO Says
COPENHAGEN – Novo Nordisk (NYSE: NVO) is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States
Novo Nordisk Lifts Curbs on Wegovy Prescriptions in the US, CEO Says Read More »
Novavax and UK Officially Terminate COVID-19 Vaccine Supply Contract
On Tuesday, Novavax (NASDAQ: NVAX) said it has entered into a termination and settlement agreement with the UK Health Security
Novavax and UK Officially Terminate COVID-19 Vaccine Supply Contract Read More »
Germany’s Fresenius Beats Q3 Estimates, Raises Full-Year Outlook
On Wednesday, Fresenius raised its full-year outlook after beating third-quarter expectations, citing strong performances at its Kabi and Helios divisions
Germany’s Fresenius Beats Q3 Estimates, Raises Full-Year Outlook Read More »
Novo Nordisk Stock Jumps as Q3 Wegovy Sales Top Estimates
COPENHAGEN – On Wednesday, Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug, reassuring investors worried that
Novo Nordisk Stock Jumps as Q3 Wegovy Sales Top Estimates Read More »
Novo Nordisk is Aware of 10 Deaths From Compounded Weight-Loss Drug Copies
LONDON – On Wednesday, Novo Nordisk (NYSE: NVO) chief financial officer Karsten Munk Knudsen said the company was aware of
Novo Nordisk is Aware of 10 Deaths From Compounded Weight-Loss Drug Copies Read More »
AstraZeneca Shares Slump on Report of Potential China Probe Fallout
On Tuesday, AstraZeneca shares recorded their worst day since March 2020 after a report that dozens of the drugmaker’s senior
AstraZeneca Shares Slump on Report of Potential China Probe Fallout Read More »
BioNTech Lowers 2024 Revenue Outlook on COVID-19 Seasonality and Inventory Write-downs
On Monday, BioNTech (NASDAQ: BNTX), the German drugmaker, lowered its guidance for full-year revenue, citing COVID-19 uptake and price levels,
BioNTech Lowers 2024 Revenue Outlook on COVID-19 Seasonality and Inventory Write-downs Read More »
Americans Seeking Weight-Loss Drugs Face Supply and Insurance Hurdles
Americans are still eagerly seeking prescriptions for Eli Lilly’s (NYSE: LLY) and Novo Nordisk’s (NYSE: NVO) weight-loss and diabetes drugs
Americans Seeking Weight-Loss Drugs Face Supply and Insurance Hurdles Read More »
EU Regulators Set Deadline for Decision on Novo Holdings’ Catalent Acquisition
BRUSSELS/LONDON – EU antitrust regulators will decide by December 6 whether to clear Novo Holdings’ acquisition of contract drug manufacturer
EU Regulators Set Deadline for Decision on Novo Holdings’ Catalent Acquisition Read More »
Novartis CEO ‘Very Confident’ on Sales Target, Doesn’t Fear Patent Cliff – Newspaper
ZURICH – Novartis (NYSE: NVS) expects to increase its annual sales by at least 5% per year in the coming
Novartis CEO ‘Very Confident’ on Sales Target, Doesn’t Fear Patent Cliff – Newspaper Read More »
Healthcare
Smith & Nephew (NYSE: SNN) Cuts Annual Revenue Growth Forecast, Stock Plummets
On Thursday, Smith & Nephew (NYSE: SNN), the British medical equipment maker, cut its annual underlying revenue growth forecast due
Smith & Nephew (NYSE: SNN) Cuts Annual Revenue Growth Forecast, Stock Plummets Read More »
Infections Linked to McDonald’s E. Coli Outbreak Rise to 90, US CDC Says
On Wednesday, the U.S. Centers for Disease Control and Prevention said that the number of infected people from the E.coli
Infections Linked to McDonald’s E. Coli Outbreak Rise to 90, US CDC Says Read More »
AstraZeneca (NASDAQ: AZN) Stock Falls on News of China President’s Investigation
AstraZeneca’s (NASDAQ: AZN) China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending
AstraZeneca (NASDAQ: AZN) Stock Falls on News of China President’s Investigation Read More »
GSK (NYSE: GSK) Cuts 2024 Vaccine Sales Forecast Amid Soft Demand for RSV and Shingles Shots
On Wednesday, GSK (NYSE: GSK) said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory
